Assessment of menstrual health in adolescent and young adults with sickle cell disease
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Brittany Notice und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Menorrhagia, Anemia, Sickle Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Hemophilia Foundation, Dudley Fund, Hemophilia of Georgia.
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is associated with hypercoagulability, but adults with SCD also have an increased incidence of bleeding including heavy menstrual bleeding (HMB). HMB is common among adolescent females, but the impact of HMB in pediatric SCD is unclear. The objectives of this study were to examine menstrual health status, knowledge, and quality of life (QOL).
Methods
We performed a single‐institutional multi‐clinic cross‐sectional study comprised of a five‐part survey in pediatric participants with SCD. The survey included the validated Menstrual Bleeding Questionnaire (MBQ) and Self‐administered Bleeding Assessment Tool (Self‐BAT).
Results
Forty‐eight participants with a median age of 16 years (range: 12–21 years) completed the study. The mean age at onset of menarche was 13 ± 1.3 years. On the MBQ, 29% reported heavy/very heavy menstrual flow, 61% reported moderate or severe dysmenorrhea, and 96% had menses lasting less than 1 week. The Self‐BAT revealed that 42% of participants reported a history of HMB. Participants with severe dysmenorrhea or HMB had higher MBQ scores, corresponding to worse QOL. Despite this, less than 20% of participants had attempted any hormonal therapy for menstrual regulation. The odds of hormonal therapy utilization were comparable among participants on hydroxyurea versus not on hydroxyurea (odds ratio 1.58, 95% confidence interval [CI]: 0.33–7.56).
Conclusions
The prevalence of HMB and dysmenorrhea is high among adolescents and young women with SCD. Strategies that incorporate menstrual health assessment into routine medical care in this population would help address this important area of pediatric health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
- Morehouse School of Medicine, Atlanta, Georgia, USA.
- Aflac Cancer and Blood Disorder Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Nursing & Allied Health Research & Evidence-Based Practice Department, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Department of Pediatrics, Biostatistics Core, Emory School of Medicine, Atlanta, Georgia, USA.
- Department of Obstetrics and Gynecology, Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Glaivy Batsuli
Förderung
- National Hemophilia Foundation
- Dudley Fund
- Hemophilia of Georgia
Zitieren
APA
Notice, B., Soffer, E., Tickle, K., Xiang, Y., Gee, B. E., Sidonio, R. F., Sokkary, N., & Batsuli, G. (2024). Assessment of menstrual health in adolescent and young adults with sickle cell disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30727
Vancouver
Notice B, Soffer E, Tickle K, Xiang Y, Gee BE, Sidonio RF, et al. Assessment of menstrual health in adolescent and young adults with sickle cell disease. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30727
BibTeX
@article{Notice2024,
author = {Notice, Brittany and Soffer, Elizabeth and Tickle, Kelly and Xiang, Yijin and Gee, Beatrice E and Sidonio, Robert F and Sokkary, Nancy and Batsuli, Glaivy},
title = {Assessment of menstrual health in adolescent and young adults with sickle cell disease},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30727}
}
EUVIMED